RSLS fundamentals
ReShape Lifesciences, Inc. earnings per share and revenue
RSLS earnings per share for the last quarter are -3.02 USD whereas the estimation was -5.80 USD which accounts for 47.87% surprise. Company revenue for the same period amounts to 2.29 M USD despite the estimated figure of 2.51 M USD. Estimated earnings per share for the next quarter are -4.06 USD, and revenue is expected to reach 3.17 M USD. Also watch annual changes over time to get a bigger picture of RSLS earnings per share and revenue dynamics.
Next report date
≈
In 4 daysReport periodQ4 2024
EPS estimate−4.06USD
Revenue estimate3.17 MUSD
EPS
Forecast
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
−2.40 K
−1.80 K
−1.20 K
−600.00
0.00
Reported
Estimate
Currency: USD
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Reported
−2.06 K
−81.31
−62.64
−59.16
−0.18
—
−4.28
−3.02
—
—
Estimate
−2.06 K
−244.18
−103.82
−69.60
−10.44
−9.28
−6.96
−5.80
−4.06
—
Surprise
0.00%
+66.70%
+39.66%
+15.00%
+98.28%
—
+38.54%
+47.87%
—
—
Revenue
Forecast
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
0.00
800.00 K
1.60 M
2.40 M
3.20 M
Reported
Estimate
Currency: USD
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Reported
3.11 M
2.29 M
2.25 M
2.15 M
1.99 M
1.94 M
1.97 M
2.29 M
—
—
Estimate
3.11 M
2.51 M
2.61 M
2.40 M
2.21 M
2.10 M
2.21 M
2.51 M
3.17 M
—
Surprise
0.00%
−8.99%
−13.64%
−10.21%
−9.96%
−7.60%
−11.05%
−8.61%
—
—